Advanced lipid peroxidation end-products in Alexander's disease

Brain Research

Volumn 787, Issue 1, 1998, Pages 15-18

  Castellani, R J ^a   Perry, G ^b   Harris, P L R ^b   Cohen, Mark L ^b   Sayre, Lawrence M ^b   Salomon, Robert G ^b   Smith, M A ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 Hydroxy 2 nonenal; Alexander's disease; Immunohistochemistry; Rosenthal fiber

Indexed keywords

ADOLESCENT; ALEXANDER DISEASE; ANTIBODY LABELING; ARTICLE; CHILD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; BRAIN DISEASES; CHILD; DEMYELINATING DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION;

EID: 0032536749     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01224-9     Document Type: Article

References (24)

1. [1] W.S. Alexander, Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant, Brain 72 (1949) 373-381.
2. [2] D. Borrett, L.E. Becker, Alexander's disease: a disease of astrocytes, Brain 108 (1985) 367-385.
3. [3] R. Castellani, M.A. Smith, P.L. Richey, R. Kalaria, P. Gambetti, G. Perry, Evidence for oxidative stress in Pick disease and corticobasal degeneration, Brain Res. 696 (1995) 268-271.
4. [4] R. Castellani, M.A. Smith, P.L. Richey, G. Perry, Glycoxidation and oxidative stress in Parkinson's disease and diffuse Lewy body disease, Brain Res. 737 (1996) 195-200.
5. [5] R.J. Castellani, G. Perry, P.L.R. Harris, V.M. Monnier, M.L. Cohen, M.A. Smith, Advanced glycation modification of Rosenthal fibers in Alexander's disease, Neurosci. Lett. (1997) in press.
6. [6] A.K. Dinda, C. Sarkar, S. Roy, Rosenthal fibers: an imunohistochemical, ultrastructural, and immunoelectron microscopic study, Acta Neuropathol. 79 (1990) 456-460.
7. [7] S. Duckett, R.J. Schwartzman, J. Osterholm, L.B. Rorke, D. Friedman, T.L. McLellan, Biopsy diagnosis of familial Alexander's disease, Pediatr. Neurosurg. 18 (1992) 134-138.
8. [8] H. Esterbauer, R.J. Schaur, H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes, Free Radic. Biol. Med. 11 (1991) 81-128.
9. [9] T. Iwaki, A. Kume-Iwaki, R.K. Liem, J.E. Goldman, Alpha B crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brains, Cell 57 (1989) 71-78.
10. [10] T. Iwaki, A. Iwaki, J. Tateishi, S. Yoshiyuki, J.E. Goldman, Alpha B crystallin and 270-kDa heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers, Am. J. Pathol. 143 (1993) 487-495.
11. [11] Y. Kress, F. Gaskin, D.S. Horoupian, C. Brosnan, Nickel induction of Rosenthal fibers in rat brain, Brain Res. 210 (1981) 419-425.
12. [12] V. Manetto, G. Perry, M. Tabaton, P. Mulvihill, V.A. Fried, H.T. Smith, P. Gambetti, L. Autilio-Gambetti, Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4501-4505.
13. [13] D.V. Nadkarni, L.M. Sayre, Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal, Chem. Res. Toxicol. 8 (1995) 284-291.
14. [14] L.M. Sayre, P.K. Arora, R.S. Iyer, R.G. Salomon, Pyrrole formation from 4-hydroxynonenal and primary amines, Chem. Res. Toxicol. 6 (1993) 19-22.
15. [15] L.M. Sayre, W. Sha, G. Xu, K. Kaur, D. Nadkarni, G. Subbanagounder, R.G. Salomon, Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal, Chem. Res. Toxicol. 9 (1996) 1194-1201.
16. [16] L.M. Sayre, D.A. Zelasko, P.L.R. Harris, G. Perry, R.G. Salomon, M.A. Smith, 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem. 68 (1997) 2092-2097.
17. [17] J.D. Schwankhaus, J.E. Parisi, W.R. Gulledge, L. Chin, R.D. Currier, Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia, Neurology 45 (1995) 2266-2271.
18. [18] M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.-D. Yan, D. Stern, L.M. Sayre, V.M. Monnier, G. Perry, Advanced Maillard reaction end products are associated with Alzheimer's disease pathology, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 5710-5714.
19. [19] M.A. Smith, M. Rudnicka-Nawrot, P.L. Richey, D. Praprotnik, P. Mulvihill, C.A. Miller, L.M. Sayre, G. Perry, Carbonyl-related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, J. Neurochem. 64 (1995) 2660-2666.
20. [20] M.A. Smith, S.L. Siedlak, P.L. Richey, R.H. Nagaraj, A. Elhammer, G. Perry, Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer's disease, Brain Res. 717 (1996) 99-108.
21. [21] M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal, N. Kowall, Oxidative damage in Alzheimer's, Nature 382 (1996) 120-121.
22. [22] M.A. Smith, P.L.R. Harris, L.M. Sayre, J.S. Beckman, G. Perry, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci. 17 (1997) 2653-2657.
23. [23] L.A. Sternberger (Ed.), Immunocytochemistry, Wiley, New York, 1986.
24. [24] K. Uchida, L.I. Szweda, H.-Z. Chae, E.R. Stadtman, Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8742-8746.